For prostate cancer, SSTR1 was found to be the primary receptor expressed in the case of prostate neoplasias, amongst 80 different samples [209]; this overexpression of SSTR1 has been also documented by other researchers [210,211]. The gene discussed is SSTR1; the disease is prostate carcinoma.